Saito T - Search Results

1

Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells.

Tanaka A, Nishikawa H, Noguchi S, Sugiyama D, Morikawa H, Takeuchi Y, Ha D, Shigeta N, Kitawaki T, Maeda Y, Saito T, Shinohara Y, Kameoka Y, Iwaisako K, Monma F, Ohishi K, Karbach J, Jäger E, Sawada K, Katayama N, Takahashi N, Sakaguchi S. Tanaka A, et al. Among authors: saito t. J Exp Med. 2020 Feb 3;217(2):e20191009. doi: 10.1084/jem.20191009. J Exp Med. 2020. PMID: 31704808 Free PMC article.

2

High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine.

Saito T, Wada H, Yamasaki M, Miyata H, Nishikawa H, Sato E, Kageyama S, Shiku H, Mori M, Doki Y. Saito T, et al. Vaccine. 2014 Oct 14;32(45):5901-7. doi: 10.1016/j.vaccine.2014.09.002. Epub 2014 Sep 13. Vaccine. 2014. PMID: 25218300 Clinical Trial.

3

Detection of self-reactive CD8⁺ T cells with an anergic phenotype in healthy individuals.

Maeda Y, Nishikawa H, Sugiyama D, Ha D, Hamaguchi M, Saito T, Nishioka M, Wing JB, Adeegbe D, Katayama I, Sakaguchi S. Maeda Y, et al. Among authors: saito t. Science. 2014 Dec 19;346(6216):1536-40. doi: 10.1126/science.aaa1292. Science. 2014. PMID: 25525252

4

Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.

Saito T, Nishikawa H, Wada H, Nagano Y, Sugiyama D, Atarashi K, Maeda Y, Hamaguchi M, Ohkura N, Sato E, Nagase H, Nishimura J, Yamamoto H, Takiguchi S, Tanoue T, Suda W, Morita H, Hattori M, Honda K, Mori M, Doki Y, Sakaguchi S. Saito T, et al. Nat Med. 2016 Jun;22(6):679-84. doi: 10.1038/nm.4086. Epub 2016 Apr 25. Nat Med. 2016. PMID: 27111280

5

Depletion of central memory CD8⁺ T cells might impede the antitumor therapeutic effect of Mogamulizumab.

Maeda Y, Wada H, Sugiyama D, Saito T, Irie T, Itahashi K, Minoura K, Suzuki S, Kojima T, Kakimi K, Nakajima J, Funakoshi T, Iida S, Oka M, Shimamura T, Doi T, Doki Y, Nakayama E, Ueda R, Nishikawa H. Maeda Y, et al. Among authors: saito t. Nat Commun. 2021 Dec 14;12(1):7280. doi: 10.1038/s41467-021-27574-0. Nat Commun. 2021. PMID: 34907192 Free PMC article. Clinical Trial.

6

Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumors.

Saito T, Kurose K, Kojima T, Funakoshi T, Sato E, Nishikawa H, Nakajima J, Seto Y, Kakimi K, Iida S, Doki Y, Oka M, Ueda R, Wada H. Saito T, et al. Nagoya J Med Sci. 2021 Nov;83(4):827-840. doi: 10.18999/nagjms.83.4.827. Nagoya J Med Sci. 2021. PMID: 34916725 Free PMC article. Clinical Trial.

7

Neural-net-based cell deconvolution from DNA methylation reveals tumor microenvironment associated with cancer prognosis.

Yasumizu Y, Hagiwara M, Umezu Y, Fuji H, Iwaisako K, Asagiri M, Uemoto S, Nakamura Y, Thul S, Ueyama A, Yokoi K, Tanemura A, Nose Y, Saito T, Wada H, Kakuda M, Kohara M, Nojima S, Morii E, Doki Y, Sakaguchi S, Ohkura N. Yasumizu Y, et al. Among authors: saito t. NAR Cancer. 2024 May 15;6(2):zcae022. doi: 10.1093/narcan/zcae022. eCollection 2024 Jun. NAR Cancer. 2024. PMID: 38751935 Free PMC article.

8

Targeted therapy for drug-tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours.

Ishida T, Takahashi T, Kurokawa Y, Nishida T, Hirota S, Serada S, Fujimoto M, Naka T, Teranishi R, Saito T, Yamashita K, Tanaka K, Yamamoto K, Makino T, Yamasaki M, Nakajima K, Eguchi H, Doki Y. Ishida T, et al. Among authors: saito t. Br J Cancer. 2021 Nov;125(11):1511-1522. doi: 10.1038/s41416-021-01566-9. Epub 2021 Oct 5. Br J Cancer. 2021. PMID: 34611306 Free PMC article.

9

In situ analysis of CCR8⁺ regulatory T cells in lung cancer: suppression of GzmB⁺ CD8⁺ T cells and prognostic marker implications.

Hayashi Y, Ueyama A, Funaki S, Jinushi K, Higuchi N, Morihara H, Hirata M, Nagira Y, Saito T, Kawashima A, Iwahori K, Shintani Y, Wada H. Hayashi Y, et al. Among authors: saito t. BMC Cancer. 2024 May 23;24(1):627. doi: 10.1186/s12885-024-12363-x. BMC Cancer. 2024. PMID: 38783281 Free PMC article.

10

Laparoscopic resection for imatinib-resistant recurrent tumors of gastric gastrointestinal stromal tumors: A case report.

Sekiguchi N, Takahashi T, Nakajima K, Kurokawa Y, Saito T, Yamamoto K, Yamashita K, Tanaka K, Makino T, Eguchi H, Doki Y. Sekiguchi N, et al. Among authors: saito t. Asian J Endosc Surg. 2022 Jul;15(3):638-641. doi: 10.1111/ases.13031. Epub 2022 Feb 2. Asian J Endosc Surg. 2022. PMID: 35108756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,794 results

Search Page